Von dem Buch Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback) haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!

Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:

Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback)100%: Sherif Mohamed: Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback) (ISBN: 9783668767669) 2018, in Englisch, Taschenbuch.
Nur diese Ausgabe anzeigen…
Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases100%: Sherif Mohamed: Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases (ISBN: 9783668767652) GRIN Verlag, Erstausgabe, in Englisch, auch als eBook.
Nur diese Ausgabe anzeigen…

Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback)
4 Angebote vergleichen

Bester Preis: Fr. 48.93 ( 49.99)¹ (vom 29.09.2018)
1
9783668767652 - Sherif Mohamed: Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases
Sherif Mohamed

Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases (2001)

Lieferung erfolgt aus/von: Deutschland ~EN NW EB DL

ISBN: 9783668767652 bzw. 3668767653, vermutlich in Englisch, GRIN Verlag, neu, E-Book, elektronischer Download.

Fr. 39.14 ( 39.99)¹
versandkostenfrei, unverbindlich
Lieferung aus: Deutschland, Versandkostenfrei.
Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases: Master`s Thesis from the year 2001 in the subject Medicine - Neoplasms, Oncology, language: English, abstract: Weight loss is a common feature in patients with chronic obstructive pulmonary disease (COPD). The clinical importance of weight loss particularely loss of fat-free mass (FFM) has been demonstrated in its adverse effects on physical ... Englisch, Ebook.
2
9783668767669 - Sherif Mohamed: Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback)
Symbolbild
Sherif Mohamed

Tumour Necrosis Factor-Alpha and Weight Loss in Chronic Obstructive Pulmonary Diseases (Paperback) (2018)

Lieferung erfolgt aus/von: Vereinigtes Königreich Grossbritannien und Nordirland DE PB NW

ISBN: 9783668767669 bzw. 3668767661, in Deutsch, Bod Third Party Titles, United States, Taschenbuch, neu.

Fr. 85.50 ( 87.36)¹ + Versand: Fr. 3.29 ( 3.36)¹ = Fr. 88.79 ( 90.72)¹
unverbindlich
Von Händler/Antiquariat, The Book Depository EURO [60485773], London, United Kingdom.
Language: English. Brand new Book. Master's Thesis from the year 2001 in the subject Medicine - Neoplasms, Oncology, language: English, abstract: Weight loss is a common feature in patients with chronic obstructive pulmonary disease (COPD). The clinical importance of weight loss; particularely loss of fat-free mass (FFM) has been demonstrated in its adverse effects on physical performance and quality of life. Moreover; weight loss and a low body weight are unfavorable prognostic factors in survival, independent of lung function. Mechanisms of malnutrition in those patients are not fully understood. Several factors have been implicated. Increased resting energy expenditure (REE) contributes the main hypothesis for weight loss in COPD patients. However, not all patients with COPD who lose weight are hypermetabolic. Recent data have shown that a systemic inflammatory response is present in patients with COPD. A clear evidence for a relationship between weight loss and plasma tumour necrosis factor-alpha (TNF-*) has been shown in COPD patients. TNF-* produces a cachexia-like syndrome in animal models and has been implicated as a mediator of cachexia in several clinical conditions including cancer, chronic heart failure, cystic fibrosis and anorexia nervosa. Nutritional assessment for COPD patients is essential; to identify those individuals who will benifit from nutritional support therapies and to determine baseline values to measure the effectiveness of nutritional intervention. It includes several methods, no simple recommendation can be given regarding the best method for nutritional assessment. Because of the negative impact of malnutrition on the respiratory system in COPD patients, contributing to morbidity and mortality; it's valuable to include management strategies that increase energy balance in order to increase weight and fat-free mass in those malnourished COPD patients. The aim of this study is to determine the most valuable measurements to assess the nutritional status of COPD.
3
9783668767669 - Sherif Mohamed: Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases
Sherif Mohamed

Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases (2018)

Lieferung erfolgt aus/von: Deutschland EN PB NW

ISBN: 9783668767669 bzw. 3668767661, in Englisch, 180 Seiten, GRIN Verlag, Taschenbuch, neu.

Fr. 48.93 ( 49.99)¹
versandkostenfrei, unverbindlich
Lieferung aus: Deutschland, Versandfertig in 3 - 4 Werktagen, Versandkostenfrei. Tatsächliche Versandkosten können abweichen.
Von Händler/Antiquariat, LitoA Buch- und Medienhandel.
Master's Thesis from the year 2001 in the subject Medicine - Neoplasms, Oncology, language: English, abstract: Weight loss is a common feature in patients with chronic obstructive pulmonary disease (COPD). The clinical importance of weight loss; particularely loss of fat-free mass (FFM) has been demonstrated in its adverse effects on physical performance and quality of life. Moreover; weight loss and a low body weight are unfavorable prognostic factors in survival, independent of lung function. Mechanisms of malnutrition in those patients are not fully understood. Several factors have been implicated. Increased resting energy expenditure (REE) contributes the main hypothesis for weight loss in COPD patients. However, not all patients with COPD who lose weight are hypermetabolic. Recent data have shown that a systemic inflammatory response is present in patients with COPD. A clear evidence for a relationship between weight loss and plasma tumour necrosis factor-alpha (TNF-*) has been shown in COPD patients. TNF-* produces a cachexia-like syndrome in animal models and has been implicated as a mediator of cachexia in several clinical conditions including cancer, chronic heart failure, cystic fibrosis and anorexia nervosa. Nutritional assessment for COPD patients is essential; to identify those individuals who will benifit from nutritional support therapies and to determine baseline values to measure the effectiveness of nutritional intervention. It includes several methods, no simple recommendation can be given regarding the best method for nutritional assessment. Because of the negative impact of malnutrition on the respiratory system in COPD patients, contributing to morbidity and mortality; it's valuable to include management strategies that increase energy balance in order to increase weight and fat-free mass in those malnourished COPD patients. The aim of this study is to determine the most valuable measurements to assess the nutritional status of... Taschenbuch, Label: GRIN Verlag, GRIN Verlag, Produktgruppe: Book, Publiziert: 2018-08-03, Studio: GRIN Verlag.
4
9783668767652 - Sherif Mohamed: Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases
Sherif Mohamed

Tumour necrosis factor-alpha and weight loss in chronic obstructive pulmonary diseases (2018)

Lieferung erfolgt aus/von: Deutschland ~EN NW FE EB DL

ISBN: 9783668767652 bzw. 3668767653, vermutlich in Englisch, 173 Seiten, GRIN Verlag, neu, Erstausgabe, E-Book, elektronischer Download.

Fr. 39.14 ( 39.99)¹
versandkostenfrei, unverbindlich
Lieferung aus: Deutschland, Download sofort lieferbar.
eBooks, eBook Download (PDF), 1. Auflage, Master's Thesis from the year 2001 in the subject Medicine - Neoplasms, Oncology, language: English, abstract: Weight loss is a common feature in patients with chronic obstructive pulmonary disease (COPD). The clinical importance of weight loss; particularely loss of fat-free mass (FFM) has been demonstrated in its adverse effects on physical performance and quality of life. Moreover; weight loss and a low body weight are unfavorable prognostic factors in survival, independent of lung function. Mechanisms of malnutrition in those patients are not fully understood. Several factors have been implicated. Increased resting energy expenditure (REE) contributes the main hypothesis for weight loss in COPD patients. However, not all patients with COPD who lose weight are hypermetabolic. Recent data have shown that a systemic inflammatory response is present in patients with COPD. A clear evidence for a relationship between weight loss and plasma tumour necrosis factor-alpha (TNF-*) has been shown in COPD patients. TNF-* produces a cachexia-like syndrome in animal models and has been implicated as a mediator of cachexia in several clinical conditions including cancer, chronic heart failure, cystic fibrosis and anorexia nervosa. Nutritional assessment for COPD patients is essential; to identify those individuals who will benifit from nutritional support therapies and to determine baseline values to measure the effectiveness of nutritional intervention. It includes several methods, no simple recommendation can be given regarding the best method for nutritional assessment. Because of the negative impact of malnutrition on the respiratory system in COPD patients, contributing to morbidity and mortality; it's valuable to include management strategies that increase energy balance in order to increase weight and fat-free mass in those malnourished COPD patients. The aim of this study is to determine the most valuable measurements to assess the nutritional status of COPD patients; as regards the anthropometric measurements, the somatic and visceral proteins and markers of inflammation; and to evaluate the correlation between serum TNF-* levels and weight loss among those patients; as a trial to improve their clinical prognosis and quality of life.
Lade…